Influence of CYP2D6 ,CYP3A4 ,CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of CYP2D6
,CYP3A4
,CYP3A5
and ABCB1
Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers
Authors
Keywords
-
Journal
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Volume 122, Issue 6, Pages 596-605
Publisher
Wiley
Online
2018-01-12
DOI
10.1111/bcpt.12960
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effective phospholipids removing microelution-solid phase extraction LC-MS/MS method for simultaneous plasma quantification of aripiprazole and dehydro-aripiprazole: Application to human pharmacokinetic studies
- (2018) Aneta Wojnicz et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions
- (2017) C Rafaniello et al. PHARMACOGENOMICS JOURNAL
- Population pharmacokinetics of aripiprazole in healthy Korean subjects
- (2016) Ji-Young Jeon et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Evaluation of the Relationship Between Pharmacokinetics and the Safety of Aripiprazole and Its Cardiovascular Effects in Healthy Volunteers
- (2016) Carmen Belmonte et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients
- (2015) Karen van der Weide et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases
- (2015) Mayumi Yoshimori et al. Cancer Medicine
- The Influence of the CYP3A4*22 Polymorphism on Serum Concentration of Quetiapine in Psychiatric Patients
- (2014) Karen van der Weide et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effects of Genetic Polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia
- (2014) Takeshi Suzuki et al. THERAPEUTIC DRUG MONITORING
- Pharmacokinetics and pharmacodinamics of psychotropic drugs: effect of sex
- (2013) Donatella Marazziti et al. CNS SPECTRUMS
- PharmGKB summary
- (2012) Jatinder Lamba et al. Pharmacogenetics and Genomics
- Antipsychotic drug dosage and therapeutic response in schizophrenia is influenced byABCB1genotypes: a study from a south Indian perspective
- (2012) Neetha N Vijayan et al. PHARMACOGENOMICS
- Therapeutic Drug Monitoring of Common Antipsychotics
- (2012) Lisbeth Patteet et al. THERAPEUTIC DRUG MONITORING
- Relationship between P-glycoprotein and second-generation antipsychotics
- (2011) Tim Moons et al. PHARMACOGENOMICS
- A Systematic Review of Aripiprazole—Dose, Plasma Concentration, Receptor Occupancy, and Response
- (2010) Anna Sparshatt et al. JOURNAL OF CLINICAL PSYCHIATRY
- Pharmacokinetics of acute and sub-chronic aripiprazole in P-glycoprotein deficient mice
- (2010) Katrin M. Kirschbaum et al. NEUROPHARMACOLOGY
- Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
- (2010) D Wang et al. PHARMACOGENOMICS JOURNAL
- Gender differences in drug toxicity
- (2010) Tamara J. Nicolson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Aripiprazole brain concentration is altered in P-glycoprotein deficient mice
- (2009) Jun-Sheng Wang et al. SCHIZOPHRENIA RESEARCH
- Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients
- (2008) Jung-Ryul Kim et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active Moiety
- (2008) Arzu Gunes et al. THERAPEUTIC DRUG MONITORING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search